{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:32:17Z","timestamp":1776781937729,"version":"3.51.2"},"reference-count":22,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/etm.2017.4406","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T10:38:44Z","timestamp":1493375924000},"page":"3563-3566","source":"Crossref","is-referenced-by-count":21,"title":["Early clinical characteristics of bacterial endophthalmitis in retinopathy of prematurity after intravitreal bevacizumab injection: A case report"],"prefix":"10.3892","volume":"13","author":[{"given":"Jianxun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoman","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,28]]},"reference":[{"key":"key20180108134933_b1-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"key":"key20180108134933_b2-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bjo.2007.126201","article-title":"Retinopathy of prematurity in the United States","volume":"92","author":"Lad","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key20180108134933_b3-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","article-title":"Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity","volume":"245","author":"Chung","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key20180108134933_b4-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"key":"key20180108134933_b5-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/IAE.0b013e318159ec6b","article-title":"Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity","volume":"28","author":"Quiroz-Mercado","year":"2008","journal-title":"Retina"},{"key":"key20180108134933_b6-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","article-title":"Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity","volume":"38","author":"Travassos","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key20180108134933_b7-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"key20180108134933_b8-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","article-title":"Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"key20180108134933_b9-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: A comprehensive review","volume":"24","author":"Jager","year":"2004","journal-title":"Retina"},{"key":"key20180108134933_b10-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/IAE.0b013e3181633fee","article-title":"Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection","volume":"28","author":"Mason","year":"2008","journal-title":"Retina"},{"key":"key20180108134933_b11-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.ophtha.2007.05.062","article-title":"A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema","volume":"114","author":"Diabetic Retinopathy Clinical Research Network","year":"2007","journal-title":"Ophthalmology"},{"key":"key20180108134933_b12-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"key20180108134933_b13-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1542\/peds.112.6.1248","article-title":"Screening for retinoblastoma: Presenting signs as prognosticators of patient and ocular survival","volume":"112","author":"Abramson","year":"2003","journal-title":"Pediatrics"},{"key":"key20180108134933_b14-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ophtha.2009.07.041","article-title":"Severe intraocular inflammation after intravitreal injection of bevacizumab","volume":"117","author":"Sato","year":"2010","journal-title":"Ophthalmology"},{"key":"key20180108134933_b15-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1542\/peds.101.4.654","article-title":"Candida sepsis and association with retinopathy of prematurity","volume":"101","author":"Mittal","year":"1998","journal-title":"Pediatrics"},{"key":"key20180108134933_b16-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3928\/0191-3913-19900301-12","article-title":"Long-term follow-up of Candida endophthalmitis in the premature infant","volume":"27","author":"Annable","year":"1990","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"key20180108134933_b17-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0039-6257(89)90038-6","article-title":"Infantile endogenous Candida endophthalmitis presenting as a cataract","volume":"34","author":"Clinch","year":"1989","journal-title":"Surv Ophthalmol"},{"key":"key20180108134933_b18-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0002-9394(02)01600-8","article-title":"Bilateral presumed endogenous candida endophthalmitis and stage 3 retinopathy of prematurity","volume":"134","author":"Gago","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key20180108134933_b19-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00055735-200202000-00004","article-title":"Postoperative endophthalmitis","volume":"13","author":"Mamalis","year":"2002","journal-title":"Curr Opin Ophthalmol"},{"key":"key20180108134933_b20-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","article-title":"No authors listed: Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group","volume":"113","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"key20180108134933_b21-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.ophtha.2014.02.001","article-title":"Microbiological spectrum and antibiotic sensitivity in endophthalmitis: A 25-year review","volume":"121","author":"Gentile","year":"2014","journal-title":"Ophthalmology"},{"key":"key20180108134933_b22-etm-0-0-4406","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IAE.0b013e3181644ad2","article-title":"Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity","volume":"28","author":"Lalwani","year":"2008","journal-title":"Retina"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T01:02:33Z","timestamp":1658970153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.4406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,28]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,28]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/etm.2017.4406"],"URL":"https:\/\/doi.org\/10.3892\/etm.2017.4406","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,28]]}}}